Swiss National Bank Sells 102,400 Shares of Corteva, Inc. $CTVA

Swiss National Bank lowered its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 4.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,966,383 shares of the company’s stock after selling 102,400 shares during the quarter. Swiss National Bank owned 0.29% of Corteva worth $132,986,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of CTVA. Empirical Finance LLC lifted its stake in Corteva by 0.6% in the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after buying an additional 153 shares in the last quarter. Fox Run Management L.L.C. raised its holdings in shares of Corteva by 5.1% during the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after acquiring an additional 164 shares during the period. IFG Advisory LLC lifted its position in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock valued at $660,000 after acquiring an additional 166 shares in the last quarter. United Community Bank boosted its stake in Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after purchasing an additional 176 shares during the period. Finally, Binnacle Investments Inc increased its holdings in Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after purchasing an additional 181 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Down 2.6%

Corteva stock opened at $76.30 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The company’s 50-day moving average is $73.40 and its 200-day moving average is $69.06. The firm has a market capitalization of $51.31 billion, a PE ratio of 48.29, a P/E/G ratio of 2.68 and a beta of 0.72. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $80.90.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter last year, the company posted $0.32 earnings per share. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.15% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CTVA. Rothschild & Co Redburn reduced their price objective on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. CICC Research raised their price target on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 11th. Citigroup lifted their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Bank of America boosted their price objective on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Finally, Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.